Lv11
58 积分 2023-07-25 加入
Pharmacokinetic, pharmacodynamic and subjective and effects of the novel 5-HT2A receptor agonist GM-2505 in healthy volunteers
2小时前
已关闭
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
7天前
已完结
New epilepsy therapies in development
14天前
已完结
Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy
14天前
已完结
22. GM-2505 has Rapid Onset Antidepressant Activity and Causes Dose-Dependent Changes in qEEG With Increasing 5-HT2A Receptor Occupancy
23天前
已完结
The polypharmacology of psychedelics reveals multiple targets for potential therapeutics
1个月前
已完结
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder
1个月前
已完结
A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy
7个月前
已完结
Advancements in NMDA Receptor-Targeted Antidepressants: From d-Cycloserine Discovery to Preclinical Efficacy of Lu AF90103
7个月前
已完结
GW117 induces anxiolytic effects by improving hippocampal functions
8个月前
已关闭
皖公网安备34019202002308
